FibroGen
FGEN
#9980
Rank
NZ$61.48 M
Marketcap
NZ$15.20
Share price
3.47%
Change (1 day)
-1.83%
Change (1 year)

Revenue for FibroGen (FGEN)

Revenue in 2025 (TTM): -NZ$0.21 Billion

According to FibroGen's latest financial reports the company's current revenue (TTM ) is -NZ$0.21 Billion. In 2024 the company made a revenue of -NZ$0.18 Billion a decrease over the revenue in the year 2023 that were of NZ$0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for FibroGen from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) -NZ$0.21 Billion22.18%
2024 -NZ$0.18 Billion-173.44%
2023 NZ$0.23 B5.4%
2022 NZ$0.22 B-35.66%
2021 NZ$0.34 B40.98%
2020 NZ$0.24 B-35.86%
2019 NZ$0.38 B20%
2018 NZ$0.31 B57.93%
2017 NZ$0.20 B-22.46%
2016 NZ$0.25 B-1.88%
2015 NZ$0.26 B50.44%
2014 NZ$0.17 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
NZ$7.40 B-3,731.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$0.19 B-195.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Accelerate Diagnostics
AXDX
NZ$20.2 M-109.91%๐Ÿ‡บ๐Ÿ‡ธ USA